Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
“Tirzepatide does not currently have FDA approval for cardiac risk reduction, and thus, coverage and usage are limited…
1,500 reports to HPRA on anti-obesity drug side effects
There have been over 1,500 reports of suspected adverse reactions from weight loss medication, the Health Products Regulatory…
FDA says recalled blood thinner sold across the US is unlikely to cause serious harm
A recalled generic blood thinner has drawn national attention. But the U.S. Food and Drug Administration says the…
Blood Pressure Drug Recalled Nationwide, FDA Announces
When a prescription drug is recalled, often it’s a generic version that’s being pulled from market. But this…
Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and more – STAT
Pharmalittle: We’re reading about an FDA rejection, 340B court battles, and more STATIn surprise decision, FDA rejects radiopharma therapy…
Residents face healthcare hurdles for medication
Residents who rely on provincial hospitals for chronic medication say they are repeatedly being sent home without their…
New Parkinson’s medication approved for NHS Scotland use
The Scottish Medicines Consortium (SMC) has approved Lecigon for patient use when standard medications usually used to manage…
AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise
AbCellera said on Monday its experimental menopause treatment significantly reduced the frequency and severity of hot flashes in…
Study reveals poor knowledge of drug-supplement interactions in healthcare
Researchers from the University of Coimbra, Portugal, conducted an online survey of 311 healthcare practitioners and discovered that…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
Is Repatha a Statin? What To Know About the Cholesterol Drug
Is Repatha a Statin? What To Know About the Cholesterol Drug Use left and right arrow keys to…
Heart attack: GLP-1 drug tirzepatide may cut risk by 33%
Share on PinterestA new study on the GLP-1 drug tirzepatide reveals heart health benefits for people with diabetes.…